Early Relapse of Unresectable Gallbladder Cancer after Discontinuation of Gemcitabine Monotherapy Administered for 5 Years in a Patient Who Had Complete Response to the Treatment

di Koichi Suyama, Masafumi Ikeda, Eiichiro Suzuki, Motohiro Kojima, Shuichi Mitsunaga, Satoshi Shimizu, Izumi Ohno, Hideaki Takahashi, Hiroyuki Okuyama, Akiko Kuwahara, Takuji Okusaka, Junji Furuse
Pubblicazione 2013-10-01